Nasdaq · CIK 0001956166
PMA PMA Graphene Technology Group Inc.
Insider trading from SEC Form 4. Last filing 18 d ago. Close $1.27 on Oct 9, 2026, +75% from the 52-week low and -53% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at PMA Graphene Technology Group Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | Chi Ming Lam director sell | $218k 167,865 shares | -10% | - | |
| 36Weak | Chi Ming Lam director sell | $164k 126,000 shares | -40% | - | |
| 31Weak | Chi Ming Lam director sell | $129k 99,114 shares | -24% | - | |
| 40Moderate | Chi Ming Lam director sell | $344k 270,000 shares | -39% | - | |
| 41Moderate | Chi Ming Lam director, owner sell | $413k 320,000 shares | -32% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 22, 2025 | Lam Chi Ming Officer, Director, 10% Stockholder | 627,500 4.84% of outstanding | $2.7M | May 22, 2025 | none |
| Feb 3, 2025 | Lam Chi Ming Officer, Director, 10% Stockholder | 500,000 3.85% of outstanding | $4.1M | Feb 3, 2025 | none |
Transactions
The last 12 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Chi Ming Lam director | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -120,000 | $1.30 | $156k | 1,479,751 | 18 d ago |
| Sep 25, 2026 | Chi Ming Lam director | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -47,865 | $1.30 | $62k | 1,431,886 | 18 d ago |
| Sep 22, 2026 | Chi Ming Lam director | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -120,000 | $1.30 | $156k | 198,751 | 20 d ago |
| Sep 23, 2026 | Chi Ming Lam director | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -6,000 | $1.30 | $7,805 | 192,751 | 20 d ago |
| Sep 15, 2026 | Chi Ming Lam director | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -99,114 | $1.30 | $129k | 318,751 | 28 d ago |
| Sep 9, 2026 | Chi Ming Lam director | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -150,000 | $1.25 | $188k | 537,865 | 32 d ago |
| Aug 13, 2026 | Chi Ming Lam director, owner | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -100,000 | $1.10 | $110k | 907,865 | 32 d ago |
| Sep 11, 2026 | Chi Ming Lam director | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -120,000 | $1.30 | $156k | 417,865 | 32 d ago |
| Aug 14, 2026 | Chi Ming Lam director, owner | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -100,000 | $1.37 | $137k | 807,865 | 32 d ago |
| Aug 17, 2026 | Chi Ming Lam director, owner | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -15,000 | $1.75 | $26k | 792,865 | 32 d ago |
| Aug 18, 2026 | Chi Ming Lam director, owner | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -5,000 | $1.62 | $8,116 | 787,865 | 32 d ago |
| Aug 21, 2026 | Chi Ming Lam director, owner | SOpen-market sale Class A Ordinary Sharesindirect: Held in individual account with broker | -100,000 | $1.32 | $132k | 687,865 | 32 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.